Human Drugs View

Product Information DR-XY48674_PI_01.pdf
Registration Number DR-XY48674
Generic Name Ibrutinib
Brand Name Imbruvica
Dosage Strength 420 mg
Dosage Form Film-Coated Tablet
Classification Prescription Drug (RX)
Pharmacologic Category Antineoplastic Agent (Protein Kinase Inhibitor)
Packaging PVC/PCTFE/Alu Blister Pack x 14’s
Manufacturer Cilag AG
Country of Origin Switzerland
Trader N/A
Importer Johnson & Johnson (Philippines), Inc.
Distributor
Application Type Monitored Release (Correction)
Issuance Date 28 September 2023
Expiry Date 30 March 2028